Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Overcoming challenges in the economic evaluation of interventions to optimise antibiotic use.

Journal article

Roope LSJ. et al, (2024), Commun Med (Lond), 4

Population screening requires robust evidence-genomics is no exception.

Journal article

Turnbull C. et al, (2023), Lancet

HEcoPerMed, personalized medicine from a health economic perspective: lessons learned and potential opportunities ahead.

Journal article

Rutten-van Mölken M. et al, (2023), Personalized medicine, 20, 299 - 303

Antibiotic review kit for hospitals (ARK-Hospital): a stepped-wedge cluster-randomised controlled trial.

Journal article

Llewelyn MJ. et al, (2023), Lancet Infect Dis, 23, 207 - 221

Introduction to economic evaluation in health sciences

Chapter

Mitropoulou C. et al, (2023), Economic Evaluation in Genomic and Precision Medicine, 1 - 14

Preface

Journal article

Mitropoulou C. et al, (2023), Economic Evaluation in Genomic and Precision Medicine, xiii - xiv

Load More